0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Human Vaccine Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2021-2027
Published Date: July 2021
|
Report Code: QYRE-Auto-476
Home | Market Reports | Health | Health Conditions | Infectious Diseases
Global Human Vaccine Market Size Manufacturers Supply Chain Sales Channel and Clients 2021 2027

Global Human Vaccine Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2021-2027

Code: QYRE-Auto-476
Report
July 2021
147 Pages
QYResearch
Region: Global, Europe, North America, Asia Pacific, Middle East,
Description
Table of Content
Tables & Figures
A vaccine is a biological preparation that provides active acquired immunity to a particular disease. A vaccine typically contains an agent that resembles a disease-causing microorganism and is often made from weakened or killed forms of the microbe, its toxins or one of its surface proteins.

In China, Human Vaccine key players include CNBG, Kangtai, ChengDa Bio, etc. Global top three manufacturers hold a share about 65%.

East China is the largest market, with a share about 25%, followed by South China, and North China, both have a share about 40 percent.
In terms of product, Hepatitis B is the largest segment, with a share nearly 15%. And in terms of application, the largest application is Children, followed by Adults.
Market Analysis and Insights: Global Human Vaccine Market
In 2020, the global Human Vaccine market size was US$ XX million and it is expected to reach US$ XX million by the end of 2027, with a CAGR of XX% during 2021-2027.
Global Human Vaccine Scope and Market Size
Human Vaccine market is segmented by region, by country, company, type, application and by sales channels. Players, stakeholders, and other participants in the global Human Vaccine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region, by country, company, type, application and by sales channels for the period 2016-2027.

Segment by Type, the Human Vaccine market is segmented into

Varicella
Influenza
Polio
Hepatitis A
Rabies
BCG
Hepatitis B
Pertussis, Diphtheria, Tetanus
Pneumococcal
Rota vaccine

Segment by Application, the Human Vaccine market is segmented into

Adults
Children
Regional and Country-level Analysis:
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Rest of Asia-Pacific
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Competitive Landscape and Human Vaccine Market Share Analysis
Human Vaccine market competitive landscape provides details and data information by companies. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2016-2021. It also offers detailed analysis supported by reliable statistics on sale and revenue by players for the period 2016-2021. Details included are company description, major business, Human Vaccine product introduction, recent developments, Human Vaccine sales by region, type, application and by sales channel.
The major companies include:
CNBG
Changsheng Life
Zhifei
ChengDa Bio
Kangtai
SINOVAC BIOTECH
Hissen
Walvax Biotechnology
GSK
SANOFI
Rong An
NuoCheng Bio
Hualan Bio
Tiantan biological
Changchun Baike
Adimmune
Zhongyianke Biotech
Bharat Biotech
Bavarian Nordic
Sanofi-Pasteur
Indian Immunologicals
KANGH
Henan Grand Biopharma
ZhongKe Biopharm
Zhuoyi Biological
1 Study Coverage
1.1 Human Vaccine Product Introduction
1.2 Market by Type
1.2.1 Global Human Vaccine Market Size Growth Rate by Type
1.2.2 Varicella
1.2.3 Influenza
1.2.4 Polio
1.2.5 Hepatitis A
1.2.6 Rabies
1.2.7 BCG
1.2.8 Hepatitis B
1.2.9 Pertussis, Diphtheria, Tetanus
1.2.10 Pneumococcal
1.2.11 Rota vaccine
1.3 Market by Application
1.3.1 Global Human Vaccine Market Size Growth Rate by Application
1.3.2 Adults
1.3.3 Children
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Human Vaccine Market Size Estimates and Forecasts
2.1.1 Global Human Vaccine Revenue 2016-2027
2.1.2 Global Human Vaccine Sales 2016-2027
2.2 Human Vaccine Market Size by Region: 2021 Versus 2027
2.3 Human Vaccine Sales by Region (2016-2027)
2.3.1 Global Human Vaccine Sales by Region: 2016-2021
2.3.2 Global Human Vaccine Sales Forecast by Region (2022-2027)
2.3.3 Global Human Vaccine Sales Market Share by Region (2016-2027)
2.4 Human Vaccine Market Estimates and Projections by Region (2022-2027)
2.4.1 Global Human Vaccine Revenue by Region: 2016-2021
2.4.2 Global Human Vaccine Revenue Forecast by Region (2022-2027)
2.4.3 Global Human Vaccine Revenue Market Share by Region (2016-2027)
3 Global Human Vaccine by Manufacturers
3.1 Global Top Human Vaccine Manufacturers by Sales
3.1.1 Global Human Vaccine Sales by Manufacturer (2016-2021)
3.1.2 Global Human Vaccine Sales Market Share by Manufacturer (2016-2021)
3.2 Global Top Human Vaccine Manufacturers by Revenue
3.2.1 Global Human Vaccine Revenue by Manufacturer (2016-2021)
3.2.2 Global Human Vaccine Revenue Share by Manufacturer (2016-2021)
3.3 Global Human Vaccine Price by Manufacturer (2016-2021)
3.4 Competitive Landscape
3.4.1 Key Human Vaccine Manufacturers Covered: Ranking by Revenue
3.4.2 Global Human Vaccine Market Concentration Ratio (CR5 and HHI) & (2016-2021)
3.4.3 Global Human Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.5 Global Human Vaccine Manufacturing Base Distribution, Product Type
3.5.1 Human Vaccine Manufacturers Manufacturing Base Distribution, Headquarters
3.5.2 Manufacturers Human Vaccine Product Type
3.5.3 Date of International Manufacturers Enter into Human Vaccine Market
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Company Profiles
4.1 CNBG
4.1.1 CNBG Corporation Information
4.1.2 CNBG Description, Business Overview
4.1.3 CNBG Human Vaccine Products Offered
4.1.4 CNBG Human Vaccine Sales, Revenue and Gross Margin (2016-2021)
4.1.5 CNBG Human Vaccine Revenue by Product
4.1.6 CNBG Human Vaccine Revenue by Application
4.1.7 CNBG Human Vaccine Revenue by Geographic Area
4.1.8 CNBG Human Vaccine Revenue by Sales Channel
4.1.9 CNBG Recent Development
4.2 Changsheng Life
4.2.1 Changsheng Life Corporation Information
4.2.2 Changsheng Life Description, Business Overview
4.2.3 Changsheng Life Human Vaccine Products Offered
4.2.4 Changsheng Life Human Vaccine Sales, Revenue and Gross Margin (2016-2021)
4.2.5 Changsheng Life Human Vaccine Revenue by Product
4.2.6 Changsheng Life Human Vaccine Revenue by Application
4.2.7 Changsheng Life Human Vaccine Revenue by Geographic Area
4.2.8 Changsheng Life Human Vaccine Revenue by Sales Channel
4.2.9 Changsheng Life Recent Development
4.3 Zhifei
4.3.1 Zhifei Corporation Information
4.3.2 Zhifei Description, Business Overview
4.3.3 Zhifei Human Vaccine Products Offered
4.3.4 Zhifei Human Vaccine Sales, Revenue and Gross Margin (2016-2021)
4.3.5 Zhifei Human Vaccine Revenue by Product
4.3.6 Zhifei Human Vaccine Revenue by Application
4.3.7 Zhifei Human Vaccine Revenue by Geographic Area
4.3.8 Zhifei Human Vaccine Revenue by Sales Channel
4.3.9 Zhifei Recent Development
4.4 ChengDa Bio
4.4.1 ChengDa Bio Corporation Information
4.4.2 ChengDa Bio Description, Business Overview
4.4.3 ChengDa Bio Human Vaccine Products Offered
4.4.4 ChengDa Bio Human Vaccine Sales, Revenue and Gross Margin (2016-2021)
4.4.5 ChengDa Bio Human Vaccine Revenue by Product
4.4.6 ChengDa Bio Human Vaccine Revenue by Application
4.4.7 ChengDa Bio Human Vaccine Revenue by Geographic Area
4.4.8 ChengDa Bio Human Vaccine Revenue by Sales Channel
4.4.9 ChengDa Bio Recent Development
4.5 Kangtai
4.5.1 Kangtai Corporation Information
4.5.2 Kangtai Description, Business Overview
4.5.3 Kangtai Human Vaccine Products Offered
4.5.4 Kangtai Human Vaccine Sales, Revenue and Gross Margin (2016-2021)
4.5.5 Kangtai Human Vaccine Revenue by Product
4.5.6 Kangtai Human Vaccine Revenue by Application
4.5.7 Kangtai Human Vaccine Revenue by Geographic Area
4.5.8 Kangtai Human Vaccine Revenue by Sales Channel
4.5.9 Kangtai Recent Development
4.6 SINOVAC BIOTECH
4.6.1 SINOVAC BIOTECH Corporation Information
4.6.2 SINOVAC BIOTECH Description, Business Overview
4.6.3 SINOVAC BIOTECH Human Vaccine Products Offered
4.6.4 SINOVAC BIOTECH Human Vaccine Sales, Revenue and Gross Margin (2016-2021)
4.6.5 SINOVAC BIOTECH Human Vaccine Revenue by Product
4.6.6 SINOVAC BIOTECH Human Vaccine Revenue by Application
4.6.7 SINOVAC BIOTECH Human Vaccine Revenue by Geographic Area
4.6.8 SINOVAC BIOTECH Recent Development
4.7 Hissen
4.7.1 Hissen Corporation Information
4.7.2 Hissen Description, Business Overview
4.7.3 Hissen Human Vaccine Products Offered
4.7.4 Hissen Human Vaccine Sales, Revenue and Gross Margin (2016-2021)
4.7.5 Hissen Human Vaccine Revenue by Product
4.7.6 Hissen Human Vaccine Revenue by Application
4.7.7 Hissen Human Vaccine Revenue by Geographic Area
4.7.8 Hissen Recent Development
4.8 Walvax Biotechnology
4.8.1 Walvax Biotechnology Corporation Information
4.8.2 Walvax Biotechnology Description, Business Overview
4.8.3 Walvax Biotechnology Human Vaccine Products Offered
4.8.4 Walvax Biotechnology Human Vaccine Sales, Revenue and Gross Margin (2016-2021)
4.8.5 Walvax Biotechnology Human Vaccine Revenue by Product
4.8.6 Walvax Biotechnology Human Vaccine Revenue by Application
4.8.7 Walvax Biotechnology Human Vaccine Revenue by Geographic Area
4.8.8 Walvax Biotechnology Recent Development
4.9 GSK
4.9.1 GSK Corporation Information
4.9.2 GSK Description, Business Overview
4.9.3 GSK Human Vaccine Products Offered
4.9.4 GSK Human Vaccine Sales, Revenue and Gross Margin (2016-2021)
4.9.5 GSK Human Vaccine Revenue by Product
4.9.6 GSK Human Vaccine Revenue by Application
4.9.7 GSK Human Vaccine Revenue by Geographic Area
4.9.8 GSK Recent Development
4.10 SANOFI
4.10.1 SANOFI Corporation Information
4.10.2 SANOFI Description, Business Overview
4.10.3 SANOFI Human Vaccine Products Offered
4.10.4 SANOFI Human Vaccine Sales, Revenue and Gross Margin (2016-2021)
4.10.5 SANOFI Human Vaccine Revenue by Product
4.10.6 SANOFI Human Vaccine Revenue by Application
4.10.7 SANOFI Human Vaccine Revenue by Geographic Area
4.10.8 SANOFI Recent Development
4.11 Rong An
4.11.1 Rong An Corporation Information
4.11.2 Rong An Description, Business Overview
4.11.3 Rong An Human Vaccine Products Offered
4.11.4 Rong An Human Vaccine Sales, Revenue and Gross Margin (2016-2021)
4.11.5 Rong An Human Vaccine Revenue by Product
4.11.6 Rong An Human Vaccine Revenue by Application
4.11.7 Rong An Human Vaccine Revenue by Geographic Area
4.11.8 Rong An Recent Development
4.12 NuoCheng Bio
4.12.1 NuoCheng Bio Corporation Information
4.12.2 NuoCheng Bio Description, Business Overview
4.12.3 NuoCheng Bio Human Vaccine Products Offered
4.12.4 NuoCheng Bio Human Vaccine Sales, Revenue and Gross Margin (2016-2021)
4.12.5 NuoCheng Bio Human Vaccine Revenue by Product
4.12.6 NuoCheng Bio Human Vaccine Revenue by Application
4.12.7 NuoCheng Bio Human Vaccine Revenue by Geographic Area
4.12.8 NuoCheng Bio Recent Development
4.13 Hualan Bio
4.13.1 Hualan Bio Corporation Information
4.13.2 Hualan Bio Description, Business Overview
4.13.3 Hualan Bio Human Vaccine Products Offered
4.13.4 Hualan Bio Human Vaccine Sales, Revenue and Gross Margin (2016-2021)
4.13.5 Hualan Bio Human Vaccine Revenue by Product
4.13.6 Hualan Bio Human Vaccine Revenue by Application
4.13.7 Hualan Bio Human Vaccine Revenue by Geographic Area
4.13.8 Hualan Bio Recent Development
4.14 Tiantan biological
4.14.1 Tiantan biological Corporation Information
4.14.2 Tiantan biological Description, Business Overview
4.14.3 Tiantan biological Human Vaccine Products Offered
4.14.4 Tiantan biological Human Vaccine Sales, Revenue and Gross Margin (2016-2021)
4.14.5 Tiantan biological Human Vaccine Revenue by Product
4.14.6 Tiantan biological Human Vaccine Revenue by Application
4.14.7 Tiantan biological Human Vaccine Revenue by Geographic Area
4.14.8 Tiantan biological Recent Development
4.15 Changchun Baike
4.15.1 Changchun Baike Corporation Information
4.15.2 Changchun Baike Description, Business Overview
4.15.3 Changchun Baike Human Vaccine Products Offered
4.15.4 Changchun Baike Human Vaccine Sales, Revenue and Gross Margin (2016-2021)
4.15.5 Changchun Baike Human Vaccine Revenue by Product
4.15.6 Changchun Baike Human Vaccine Revenue by Application
4.15.7 Changchun Baike Human Vaccine Revenue by Geographic Area
4.15.8 Changchun Baike Recent Development
4.16 Adimmune
4.16.1 Adimmune Corporation Information
4.16.2 Adimmune Description, Business Overview
4.16.3 Adimmune Human Vaccine Products Offered
4.16.4 Adimmune Human Vaccine Sales, Revenue and Gross Margin (2016-2021)
4.16.5 Adimmune Human Vaccine Revenue by Product
4.16.6 Adimmune Human Vaccine Revenue by Application
4.16.7 Adimmune Human Vaccine Revenue by Geographic Area
4.16.8 Adimmune Recent Development
4.17 Zhongyianke Biotech
4.17.1 Zhongyianke Biotech Corporation Information
4.17.2 Zhongyianke Biotech Description, Business Overview
4.17.3 Zhongyianke Biotech Human Vaccine Products Offered
4.17.4 Zhongyianke Biotech Human Vaccine Sales, Revenue and Gross Margin (2016-2021)
4.17.5 Zhongyianke Biotech Human Vaccine Revenue by Product
4.17.6 Zhongyianke Biotech Human Vaccine Revenue by Application
4.17.7 Zhongyianke Biotech Human Vaccine Revenue by Geographic Area
4.17.8 Zhongyianke Biotech Recent Development
4.18 Bharat Biotech
4.18.1 Bharat Biotech Corporation Information
4.18.2 Bharat Biotech Description, Business Overview
4.18.3 Bharat Biotech Human Vaccine Products Offered
4.18.4 Bharat Biotech Human Vaccine Sales, Revenue and Gross Margin (2016-2021)
4.18.5 Bharat Biotech Human Vaccine Revenue by Product
4.18.6 Bharat Biotech Human Vaccine Revenue by Application
4.18.7 Bharat Biotech Human Vaccine Revenue by Geographic Area
4.18.8 Bharat Biotech Recent Development
4.19 Bavarian Nordic
4.19.1 Bavarian Nordic Corporation Information
4.19.2 Bavarian Nordic Description, Business Overview
4.19.3 Bavarian Nordic Human Vaccine Products Offered
4.19.4 Bavarian Nordic Human Vaccine Sales, Revenue and Gross Margin (2016-2021)
4.19.5 Bavarian Nordic Human Vaccine Revenue by Product
4.19.6 Bavarian Nordic Human Vaccine Revenue by Application
4.19.7 Bavarian Nordic Human Vaccine Revenue by Geographic Area
4.19.8 Bavarian Nordic Recent Development
4.20 Sanofi-Pasteur
4.20.1 Sanofi-Pasteur Corporation Information
4.20.2 Sanofi-Pasteur Description, Business Overview
4.20.3 Sanofi-Pasteur Human Vaccine Products Offered
4.20.4 Sanofi-Pasteur Human Vaccine Sales, Revenue and Gross Margin (2016-2021)
4.20.5 Sanofi-Pasteur Human Vaccine Revenue by Product
4.20.6 Sanofi-Pasteur Human Vaccine Revenue by Application
4.20.7 Sanofi-Pasteur Human Vaccine Revenue by Geographic Area
4.20.8 Sanofi-Pasteur Recent Development
4.21 Indian Immunologicals
4.21.1 Indian Immunologicals Corporation Information
4.21.2 Indian Immunologicals Description, Business Overview
4.21.3 Indian Immunologicals Human Vaccine Products Offered
4.21.4 Indian Immunologicals Human Vaccine Sales, Revenue and Gross Margin (2016-2021)
4.21.5 Indian Immunologicals Human Vaccine Revenue by Product
4.21.6 Indian Immunologicals Human Vaccine Revenue by Application
4.21.7 Indian Immunologicals Human Vaccine Revenue by Geographic Area
4.21.8 Indian Immunologicals Recent Development
4.22 KANGH
4.22.1 KANGH Corporation Information
4.22.2 KANGH Description, Business Overview
4.22.3 KANGH Human Vaccine Products Offered
4.22.4 KANGH Human Vaccine Sales, Revenue and Gross Margin (2016-2021)
4.22.5 KANGH Human Vaccine Revenue by Product
4.22.6 KANGH Human Vaccine Revenue by Application
4.22.7 KANGH Human Vaccine Revenue by Geographic Area
4.22.8 KANGH Recent Development
4.23 Henan Grand Biopharma
4.23.1 Henan Grand Biopharma Corporation Information
4.23.2 Henan Grand Biopharma Description, Business Overview
4.23.3 Henan Grand Biopharma Human Vaccine Products Offered
4.23.4 Henan Grand Biopharma Human Vaccine Sales, Revenue and Gross Margin (2016-2021)
4.23.5 Henan Grand Biopharma Human Vaccine Revenue by Product
4.23.6 Henan Grand Biopharma Human Vaccine Revenue by Application
4.23.7 Henan Grand Biopharma Human Vaccine Revenue by Geographic Area
4.23.8 Henan Grand Biopharma Recent Development
4.24 ZhongKe Biopharm
4.24.1 ZhongKe Biopharm Corporation Information
4.24.2 ZhongKe Biopharm Description, Business Overview
4.24.3 ZhongKe Biopharm Human Vaccine Products Offered
4.24.4 ZhongKe Biopharm Human Vaccine Sales, Revenue and Gross Margin (2016-2021)
4.24.5 ZhongKe Biopharm Human Vaccine Revenue by Product
4.24.6 ZhongKe Biopharm Human Vaccine Revenue by Application
4.24.7 ZhongKe Biopharm Human Vaccine Revenue by Geographic Area
4.24.8 ZhongKe Biopharm Recent Development
4.25 Zhuoyi Biological
4.25.1 Zhuoyi Biological Corporation Information
4.25.2 Zhuoyi Biological Description, Business Overview
4.25.3 Zhuoyi Biological Human Vaccine Products Offered
4.25.4 Zhuoyi Biological Human Vaccine Sales, Revenue and Gross Margin (2016-2021)
4.25.5 Zhuoyi Biological Human Vaccine Revenue by Product
4.25.6 Zhuoyi Biological Human Vaccine Revenue by Application
4.25.7 Zhuoyi Biological Human Vaccine Revenue by Geographic Area
4.25.8 Zhuoyi Biological Recent Development
5 Breakdown Data by Type
5.1 Global Human Vaccine Sales by Type (2016-2027)
5.1.1 Global Human Vaccine Sales by Type (2016-2021)
5.1.2 Global Human Vaccine Sales Forecast by Type (2022-2027)
5.1.3 Global Human Vaccine Sales Market Share by Type (2016-2027)
5.2 Global Human Vaccine Revenue Forecast by Type (2016-2027)
5.2.1 Global Human Vaccine Revenue by Type (2016-2021)
5.2.2 Global Human Vaccine Revenue Forecast by Type (2022-2027)
5.2.3 Global Human Vaccine Revenue Market Share by Type (2016-2027)
5.3 Human Vaccine Average Selling Price (ASP) by Type (2016-2027)
6 Breakdown Data by Application
6.1 Global Human Vaccine Sales by Application (2016-2027)
6.1.1 Global Human Vaccine Sales by Application (2016-2021)
6.1.2 Global Human Vaccine Sales Forecast by Application (2022-2027)
6.1.3 Global Human Vaccine Sales Market Share by Application (2016-2027)
6.2 Global Human Vaccine Revenue Forecast by Application (2016-2027)
6.2.1 Global Human Vaccine Revenue by Application (2016-2021)
6.2.2 Global Human Vaccine Revenue Forecast by Application (2022-2027)
6.2.3 Global Human Vaccine Revenue Market Share by Application (2016-2027)
6.3 Human Vaccine Average Selling Price (ASP) by Application (2016-2027)
7 North America
7.1 North America Human Vaccine Market Size YoY Growth 2016-2027
7.2 North America Human Vaccine Market Facts & Figures by Country
7.2.1 North America Human Vaccine Sales by Country (2016-2027)
7.2.2 North America Human Vaccine Revenue by Country (2016-2027)
7.3 North America Human Vaccine Sales by Type
7.4 North America Human Vaccine Sales by Application
8 Asia-Pacific
8.1 Asia-Pacific Human Vaccine Market Size YoY Growth 2016-2027
8.2 Asia-Pacific Human Vaccine Market Facts & Figures by Region
8.2.1 Asia-Pacific Human Vaccine Sales by Region (2016-2027)
8.2.2 Asia-Pacific Human Vaccine Revenue by Region (2016-2027)
8.3 Asia-Pacific Human Vaccine Sales by Type
8.4 Asia-Pacific Human Vaccine Sales by Application
9 Europe
9.1 Europe Human Vaccine Market Size YoY Growth 2016-2027
9.2 Europe Human Vaccine Market Facts & Figures by Country
9.2.1 Europe Human Vaccine Sales by Country (2016-2027)
9.2.2 Europe Human Vaccine Revenue by Country (2016-2027)
9.3 Europe Human Vaccine Sales by Type
9.4 Europe Human Vaccine Sales by Application
10 Latin America
10.1 Latin America Human Vaccine Market Size YoY Growth 2016-2027
10.2 Latin America Human Vaccine Market Facts & Figures by Country
10.2.1 Latin America Human Vaccine Sales by Country (2016-2027)
10.2.2 Latin America Human Vaccine Revenue by Country (2016-2027)
10.3 Latin America Human Vaccine Sales by Type
10.4 Latin America Human Vaccine Sales by Application
11 Middle East and Africa
11.1 Middle East and Africa Human Vaccine Market Size YoY Growth 2016-2027
11.2 Middle East and Africa Human Vaccine Market Facts & Figures by Country
11.2.1 Middle East and Africa Human Vaccine Sales by Country (2016-2027)
11.2.2 Middle East and Africa Human Vaccine Revenue by Country (2016-2027)
11.3 Middle East and Africa Human Vaccine Sales by Type
11.4 Middle East and Africa Human Vaccine Sales by Application
12 Supply Chain and Sales Channel Analysis
12.1 Human Vaccine Supply Chain Analysis
12.2 Human Vaccine Key Raw Materials and Upstream Suppliers
12.3 Human Vaccine Clients Analysis
12.4 Human Vaccine Sales Channel and Sales Model Analysis
12.4.1 Human Vaccine Distribution Channel Analysis: Indirect Sales VS Direct Sales
12.4.2 Human Vaccine Distribution Channel Analysis: Online Sales VS Offline Sales
12.4.3 Human Vaccine Distributors
13 Market Dynamics
13.1 Human Vaccine Market Drivers
13.2 Human Vaccine Market Opportunities
13.3 Human Vaccine Market Challenges
13.4 Human Vaccine Market Restraints
13.5 Porter’s Five Forces Analysis
14 Research Findings and Conclusion
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
    Table 1. Global Human Vaccine Market Size Growth Rate by Type (US$ Million): 2021 VS 2027
    Table 2. Major Manufacturers of Varicella
    Table 3. Major Manufacturers of Influenza
    Table 4. Major Manufacturers of Polio
    Table 5. Major Manufacturers of Hepatitis A
    Table 6. Major Manufacturers of Rabies
    Table 7. Major Manufacturers of BCG
    Table 8. Major Manufacturers of Hepatitis B
    Table 9. Major Manufacturers of Pertussis, Diphtheria, Tetanus
    Table 10. Major Manufacturers of Pneumococcal
    Table 11. Major Manufacturers of Rota vaccine
    Table 12. Global Human Vaccine Market Size Growth by Application (US$ Million): 2021 VS 2027
    Table 13. Global Human Vaccine Market Size by Region (US$ Million): 2021 VS 2027
    Table 14. Global Human Vaccine Sales by Region (2016-2021) & (M Doses)
    Table 15. Global Human Vaccine Sales Forecast by Region (2022-2027) & (M Doses)
    Table 16. Global Human Vaccine Revenue by Region (2016-2021) & (US$ Million)
    Table 17. Global Human Vaccine Revenue Forecast by Region (2022-2027) & (US$ Million)
    Table 18. Global Human Vaccine Sales by Manufacturer (2016-2021) & (M Doses)
    Table 19. Global Human Vaccine Sales Share by Manufacturer (2016-2021)
    Table 20. Human Vaccine Revenue by Manufacturer (2016-2021) & (US$ Million)
    Table 21. Human Vaccine Revenue Share by Manufacturer (2016-2021)
    Table 22. Key Manufacturers Human Vaccine Price (2016-2021) & (USD/Dose)
    Table 23. Ranking of Global Top Human Vaccine Manufacturers by Revenue (US$ Million) in 2020
    Table 24. Global Human Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021)
    Table 25. Global Human Vaccine by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Human Vaccine as of 2020)
    Table 26. Human Vaccine Manufacturers Manufacturing Base Distribution and Headquarters
    Table 27. Manufacturers Human Vaccine Product Type
    Table 28. Date of International Manufacturers Enter into Human Vaccine Market
    Table 29. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 30. CNBG Corporation Information
    Table 31. CNBG Description and Business Overview
    Table 32. CNBG Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2016-2021)
    Table 33. CNBG Human Vaccine Product
    Table 34. CNBG Human Vaccine Revenue (US$ Million) and Market Share by Product
    Table 35. CNBG Human Vaccine Revenue (US$ Million) and Market Share by Application
    Table 36. CNBG Human Vaccine Revenue (US$ Million) and Market Share by Geographic Area
    Table 37. CNBG Human Vaccine Revenue (US$ Million) and Market Share by Sales Channel
    Table 38. CNBG Recent Development
    Table 39. Changsheng Life Corporation Information
    Table 40. Changsheng Life Description and Business Overview
    Table 41. Changsheng Life Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2016-2021)
    Table 42. Changsheng Life Human Vaccine Product
    Table 43. Changsheng Life Human Vaccine Revenue (US$ Million) and Market Share by Product
    Table 44. Changsheng Life Human Vaccine Revenue (US$ Million) and Market Share by Application
    Table 45. Changsheng Life Human Vaccine Revenue (US$ Million) and Market Share by Geographic Area
    Table 46. Changsheng Life Human Vaccine Revenue (US$ Million) and Market Share by Sales Channel
    Table 47. Changsheng Life Recent Development
    Table 48. Zhifei Corporation Information
    Table 49. Zhifei Description and Business Overview
    Table 50. Zhifei Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2016-2021)
    Table 51. Zhifei Human Vaccine Product
    Table 52. Zhifei Human Vaccine Revenue (US$ Million) and Market Share by Product
    Table 53. Zhifei Human Vaccine Revenue (US$ Million) and Market Share by Application
    Table 54. Zhifei Human Vaccine Revenue (US$ Million) and Market Share by Geographic Area
    Table 55. Zhifei Human Vaccine Revenue (US$ Million) and Market Share by Sales Channel
    Table 56. Zhifei Recent Development
    Table 57. ChengDa Bio Corporation Information
    Table 58. ChengDa Bio Description and Business Overview
    Table 59. ChengDa Bio Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2016-2021)
    Table 60. ChengDa Bio Human Vaccine Product
    Table 61. ChengDa Bio Human Vaccine Revenue (US$ Million) and Market Share by Product
    Table 62. ChengDa Bio Human Vaccine Revenue (US$ Million) and Market Share by Application
    Table 63. ChengDa Bio Human Vaccine Revenue (US$ Million) and Market Share by Geographic Area
    Table 64. ChengDa Bio Human Vaccine Revenue (US$ Million) and Market Share by Sales Channel
    Table 65. ChengDa Bio Recent Development
    Table 66. Kangtai Corporation Information
    Table 67. Kangtai Description and Business Overview
    Table 68. Kangtai Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2016-2021)
    Table 69. Kangtai Human Vaccine Product
    Table 70. Kangtai Human Vaccine Revenue (US$ Million) and Market Share by Product
    Table 71. Kangtai Human Vaccine Revenue (US$ Million) and Market Share by Application
    Table 72. Kangtai Human Vaccine Revenue (US$ Million) and Market Share by Geographic Area
    Table 73. Kangtai Human Vaccine Revenue (US$ Million) and Market Share by Sales Channel
    Table 74. Kangtai Recent Development
    Table 75. SINOVAC BIOTECH Corporation Information
    Table 76. SINOVAC BIOTECH Description and Business Overview
    Table 77. SINOVAC BIOTECH Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2016-2021)
    Table 78. SINOVAC BIOTECH Human Vaccine Product
    Table 79. SINOVAC BIOTECH Human Vaccine Revenue (US$ Million) and Market Share by Product
    Table 80. SINOVAC BIOTECH Human Vaccine Revenue (US$ Million) and Market Share by Application
    Table 81. SINOVAC BIOTECH Human Vaccine Revenue (US$ Million) and Market Share by Geographic Area
    Table 82. SINOVAC BIOTECH Recent Development
    Table 83. Hissen Corporation Information
    Table 84. Hissen Description and Business Overview
    Table 85. Hissen Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2016-2021)
    Table 86. Hissen Human Vaccine Product
    Table 87. Hissen Human Vaccine Revenue (US$ Million) and Market Share by Product
    Table 88. Hissen Human Vaccine Revenue (US$ Million) and Market Share by Application
    Table 89. Hissen Human Vaccine Revenue (US$ Million) and Market Share by Geographic Area
    Table 90. Hissen Recent Development
    Table 91. Walvax Biotechnology Corporation Information
    Table 92. Walvax Biotechnology Description and Business Overview
    Table 93. Walvax Biotechnology Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2016-2021)
    Table 94. Walvax Biotechnology Human Vaccine Product
    Table 95. Walvax Biotechnology Human Vaccine Revenue (US$ Million) and Market Share by Product
    Table 96. Walvax Biotechnology Human Vaccine Revenue (US$ Million) and Market Share by Application
    Table 97. Walvax Biotechnology Human Vaccine Revenue (US$ Million) and Market Share by Geographic Area
    Table 98. Walvax Biotechnology Recent Development
    Table 99. GSK Corporation Information
    Table 100. GSK Description and Business Overview
    Table 101. GSK Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2016-2021)
    Table 102. GSK Human Vaccine Product
    Table 103. GSK Human Vaccine Revenue (US$ Million) and Market Share by Product
    Table 104. GSK Human Vaccine Revenue (US$ Million) and Market Share by Application
    Table 105. GSK Human Vaccine Revenue (US$ Million) and Market Share by Geographic Area
    Table 106. GSK Recent Development
    Table 107. SANOFI Corporation Information
    Table 108. SANOFI Description and Business Overview
    Table 109. SANOFI Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2016-2021)
    Table 110. SANOFI Human Vaccine Product
    Table 111. SANOFI Human Vaccine Revenue (US$ Million) and Market Share by Product
    Table 112. SANOFI Human Vaccine Revenue (US$ Million) and Market Share by Application
    Table 113. SANOFI Human Vaccine Revenue (US$ Million) and Market Share by Geographic Area
    Table 114. SANOFI Recent Development
    Table 115. Rong An Corporation Information
    Table 116. Rong An Description and Business Overview
    Table 117. Rong An Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2016-2021)
    Table 118. Rong An Human Vaccine Product
    Table 119. Rong An Human Vaccine Revenue (US$ Million) and Market Share by Product
    Table 120. Rong An Human Vaccine Revenue (US$ Million) and Market Share by Application
    Table 121. Rong An Human Vaccine Revenue (US$ Million) and Market Share by Geographic Area
    Table 122. Rong An Recent Development
    Table 123. NuoCheng Bio Corporation Information
    Table 124. NuoCheng Bio Description and Business Overview
    Table 125. NuoCheng Bio Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2016-2021)
    Table 126. NuoCheng Bio Human Vaccine Product
    Table 127. NuoCheng Bio Human Vaccine Revenue (US$ Million) and Market Share by Product
    Table 128. NuoCheng Bio Human Vaccine Revenue (US$ Million) and Market Share by Application
    Table 129. NuoCheng Bio Human Vaccine Revenue (US$ Million) and Market Share by Geographic Area
    Table 130. NuoCheng Bio Recent Development
    Table 131. Hualan Bio Corporation Information
    Table 132. Hualan Bio Description and Business Overview
    Table 133. Hualan Bio Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2016-2021)
    Table 134. Hualan Bio Human Vaccine Product
    Table 135. Hualan Bio Human Vaccine Revenue (US$ Million) and Market Share by Product
    Table 136. Hualan Bio Human Vaccine Revenue (US$ Million) and Market Share by Application
    Table 137. Hualan Bio Human Vaccine Revenue (US$ Million) and Market Share by Geographic Area
    Table 138. Hualan Bio Recent Development
    Table 139. Tiantan biological Corporation Information
    Table 140. Tiantan biological Description and Business Overview
    Table 141. Tiantan biological Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2016-2021)
    Table 142. Tiantan biological Human Vaccine Product
    Table 143. Tiantan biological Human Vaccine Revenue (US$ Million) and Market Share by Product
    Table 144. Tiantan biological Human Vaccine Revenue (US$ Million) and Market Share by Application
    Table 145. Tiantan biological Human Vaccine Revenue (US$ Million) and Market Share by Geographic Area
    Table 146. Tiantan biological Recent Development
    Table 147. Changchun Baike Corporation Information
    Table 148. Changchun Baike Description and Business Overview
    Table 149. Changchun Baike Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2016-2021)
    Table 150. Changchun Baike Human Vaccine Product
    Table 151. Changchun Baike Human Vaccine Revenue (US$ Million) and Market Share by Product
    Table 152. Changchun Baike Human Vaccine Revenue (US$ Million) and Market Share by Application
    Table 153. Changchun Baike Human Vaccine Revenue (US$ Million) and Market Share by Geographic Area
    Table 154. Changchun Baike Recent Development
    Table 155. Adimmune Corporation Information
    Table 156. Adimmune Description and Business Overview
    Table 157. Adimmune Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2016-2021)
    Table 158. Adimmune Human Vaccine Product
    Table 159. Adimmune Human Vaccine Revenue (US$ Million) and Market Share by Product
    Table 160. Adimmune Human Vaccine Revenue (US$ Million) and Market Share by Application
    Table 161. Adimmune Human Vaccine Revenue (US$ Million) and Market Share by Geographic Area
    Table 162. Adimmune Recent Development
    Table 163. Zhongyianke Biotech Corporation Information
    Table 164. Zhongyianke Biotech Description and Business Overview
    Table 165. Zhongyianke Biotech Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2016-2021)
    Table 166. Zhongyianke Biotech Human Vaccine Product
    Table 167. Zhongyianke Biotech Human Vaccine Revenue (US$ Million) and Market Share by Product
    Table 168. Zhongyianke Biotech Human Vaccine Revenue (US$ Million) and Market Share by Application
    Table 169. Zhongyianke Biotech Human Vaccine Revenue (US$ Million) and Market Share by Geographic Area
    Table 170. Zhongyianke Biotech Recent Development
    Table 171. Bharat Biotech Corporation Information
    Table 172. Bharat Biotech Description and Business Overview
    Table 173. Bharat Biotech Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2016-2021)
    Table 174. Bharat Biotech Human Vaccine Product
    Table 175. Bharat Biotech Human Vaccine Revenue (US$ Million) and Market Share by Product
    Table 176. Bharat Biotech Human Vaccine Revenue (US$ Million) and Market Share by Application
    Table 177. Bharat Biotech Human Vaccine Revenue (US$ Million) and Market Share by Geographic Area
    Table 178. Bharat Biotech Recent Development
    Table 179. Bavarian Nordic Corporation Information
    Table 180. Bavarian Nordic Description and Business Overview
    Table 181. Bavarian Nordic Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2016-2021)
    Table 182. Bavarian Nordic Human Vaccine Product
    Table 183. Bavarian Nordic Human Vaccine Revenue (US$ Million) and Market Share by Product
    Table 184. Bavarian Nordic Human Vaccine Revenue (US$ Million) and Market Share by Application
    Table 185. Bavarian Nordic Human Vaccine Revenue (US$ Million) and Market Share by Geographic Area
    Table 186. Bavarian Nordic Recent Development
    Table 187. Sanofi-Pasteur Corporation Information
    Table 188. Sanofi-Pasteur Description and Business Overview
    Table 189. Sanofi-Pasteur Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2016-2021)
    Table 190. Sanofi-Pasteur Human Vaccine Product
    Table 191. Sanofi-Pasteur Human Vaccine Revenue (US$ Million) and Market Share by Product
    Table 192. Sanofi-Pasteur Human Vaccine Revenue (US$ Million) and Market Share by Application
    Table 193. Sanofi-Pasteur Human Vaccine Revenue (US$ Million) and Market Share by Geographic Area
    Table 194. Sanofi-Pasteur Recent Development
    Table 195. Indian Immunologicals Corporation Information
    Table 196. Indian Immunologicals Description and Business Overview
    Table 197. Indian Immunologicals Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2016-2021)
    Table 198. Indian Immunologicals Human Vaccine Product
    Table 199. Indian Immunologicals Human Vaccine Revenue (US$ Million) and Market Share by Product
    Table 200. Indian Immunologicals Human Vaccine Revenue (US$ Million) and Market Share by Application
    Table 201. Indian Immunologicals Human Vaccine Revenue (US$ Million) and Market Share by Geographic Area
    Table 202. Indian Immunologicals Recent Development
    Table 203. KANGH Corporation Information
    Table 204. KANGH Description and Business Overview
    Table 205. KANGH Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2016-2021)
    Table 206. KANGH Human Vaccine Product
    Table 207. KANGH Human Vaccine Revenue (US$ Million) and Market Share by Product
    Table 208. KANGH Human Vaccine Revenue (US$ Million) and Market Share by Application
    Table 209. KANGH Human Vaccine Revenue (US$ Million) and Market Share by Geographic Area
    Table 210. KANGH Recent Development
    Table 211. Henan Grand Biopharma Corporation Information
    Table 212. Henan Grand Biopharma Description and Business Overview
    Table 213. Henan Grand Biopharma Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2016-2021)
    Table 214. Henan Grand Biopharma Human Vaccine Product
    Table 215. Henan Grand Biopharma Human Vaccine Revenue (US$ Million) and Market Share by Product
    Table 216. Henan Grand Biopharma Human Vaccine Revenue (US$ Million) and Market Share by Application
    Table 217. Henan Grand Biopharma Human Vaccine Revenue (US$ Million) and Market Share by Geographic Area
    Table 218. Henan Grand Biopharma Recent Development
    Table 219. ZhongKe Biopharm Corporation Information
    Table 220. ZhongKe Biopharm Description and Business Overview
    Table 221. ZhongKe Biopharm Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2016-2021)
    Table 222. ZhongKe Biopharm Human Vaccine Product
    Table 223. ZhongKe Biopharm Human Vaccine Revenue (US$ Million) and Market Share by Product
    Table 224. ZhongKe Biopharm Human Vaccine Revenue (US$ Million) and Market Share by Application
    Table 225. ZhongKe Biopharm Human Vaccine Revenue (US$ Million) and Market Share by Geographic Area
    Table 226. ZhongKe Biopharm Recent Development
    Table 227. Zhuoyi Biological Corporation Information
    Table 228. Zhuoyi Biological Description and Business Overview
    Table 229. Zhuoyi Biological Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2016-2021)
    Table 230. Zhuoyi Biological Human Vaccine Product
    Table 231. Zhuoyi Biological Human Vaccine Revenue (US$ Million) and Market Share by Product
    Table 232. Zhuoyi Biological Human Vaccine Revenue (US$ Million) and Market Share by Application
    Table 233. Zhuoyi Biological Human Vaccine Revenue (US$ Million) and Market Share by Geographic Area
    Table 234. Zhuoyi Biological Recent Development
    Table 235. Global Human Vaccine Sales by Type (2016-2021) & (M Doses)
    Table 236. Global Human Vaccine Sales Forecast by Type (2022-2027) & (M Doses)
    Table 237. Global Human Vaccine Revenue by Type (2016-2021) & (US$ Million)
    Table 238. Global Human Vaccine Revenue Forecast by Type (2022-2027) & (US$ Million)
    Table 239. Global Human Vaccine Sales by Application (2016-2021) & (M Doses)
    Table 240. Global Human Vaccine Sales Forecast by Application (2022-2027) & (M Doses)
    Table 241. Global Human Vaccine Revenue by Application (2016-2021) & (US$ Million)
    Table 242. Global Human Vaccine Revenue Forecast by Application (2022-2027) & (US$ Million)
    Table 243. North America Human Vaccine Sales by Country (2016-2021) & (M Doses)
    Table 244. North America Human Vaccine Sales by Country (2022-2027) & (M Doses)
    Table 245. North America Human Vaccine Revenue by Country (2016-2021) & (US$ Million)
    Table 246. North America Human Vaccine Revenue by Country (2022-2027) & (US$ Million)
    Table 247. North America Human Vaccine Sales by Type (2016-2021) & (M Doses)
    Table 248. North America Human Vaccine Sales by Application (2016-2021) & (M Doses)
    Table 249. Asia-Pacific Human Vaccine Sales by Region (2016-2021) & (M Doses)
    Table 250. Asia-Pacific Human Vaccine Sales by Region (2022-2027) & (M Doses)
    Table 251. Asia-Pacific Human Vaccine Revenue by Region (2016-2027) & (US$ Million)
    Table 252. Asia-Pacific Human Vaccine Revenue by Region (2022-2027) & (US$ Million)
    Table 253. Asia-Pacific Human Vaccine Sales by Type (2016-2021) & (M Doses)
    Table 254. Asia-Pacific Human Vaccine Sales by Application (2016-2021) & (M Doses)
    Table 255. Europe Human Vaccine Sales by Country (2016-2021) & (M Doses)
    Table 256. Europe Human Vaccine Sales by Country (2022-2027) & (M Doses)
    Table 257. Europe Human Vaccine Revenue by Country (2016-2021) & (US$ Million)
    Table 258. Europe Human Vaccine Revenue by Country (2022-2027) & (US$ Million)
    Table 259. Europe Human Vaccine Sales by Type (2016-2021) & (M Doses)
    Table 260. Europe Human Vaccine Sales by Application (2016-2021) & (M Doses)
    Table 261. Latin America Human Vaccine Sales by Country (2016-2021) & (M Doses)
    Table 262. Latin America Human Vaccine Sales by Country (2022-2027) & (M Doses)
    Table 263. Latin America Human Vaccine Revenue by Country (2016-2021) & (US$ Million)
    Table 264. Latin America Human Vaccine Revenue by Country (2022-2027) & (US$ Million)
    Table 265. Latin America Human Vaccine Sales by Type (2016-2021) & (M Doses)
    Table 266. Latin America Human Vaccine Sales by Application (2016-2021) & (M Doses)
    Table 267. Middle East and Africa Human Vaccine Sales by Country (2016-2021) & (M Doses)
    Table 268. Middle East and Africa Human Vaccine Sales by Country (2022-2027) & (M Doses)
    Table 269. Middle East and Africa Human Vaccine Revenue by Country (2016-2021) & (US$ Million)
    Table 270. Middle East and Africa Human Vaccine Revenue by Country (2022-2027) & (US$ Million)
    Table 271. Middle East and Africa Human Vaccine Sales by Type (2016-2021) & (M Doses)
    Table 272. Middle East and Africa Human Vaccine Sales by Application (2016-2021) & (M Doses)
    Table 273. Human Vaccine Key Raw Materials, Industry Status and Trend
    Table 274. Human Vaccine Key Raw Materials and Upstream Suppliers
    Table 275. Human Vaccine Clients Status and Trend
    Table 276. Human Vaccine Typical Clients
    Table 277. Human Vaccine Distributors
    Table 278. Key Drivers: Impact Analysis (2022-2027)
    Table 279. Human Vaccine Market Drivers
    Table 280. Human Vaccine Market Opportunities
    Table 281. Human Vaccine Market Challenges
    Table 282. Human Vaccine Market Restraints
    Table 283. Human Vaccine Porter’s Five Forces Analysis
    Table 284. Research Programs/Design for This Report
    Table 285. Key Data Information from Secondary Sources
    Table 286. Key Data Information from Primary Sources
List of Figures
    Figure 1. Human Vaccine Product Picture
    Figure 2. Global Human Vaccine Sales Market Share by Type in 2021 & 2027
    Figure 3. Varicella Product Picture
    Figure 4. Influenza Product Picture
    Figure 5. Polio Product Picture
    Figure 6. Hepatitis A Product Picture
    Figure 7. Rabies Product Picture
    Figure 8. BCG Product Picture
    Figure 9. Hepatitis B Product Picture
    Figure 10. Pertussis, Diphtheria, Tetanus Product Picture
    Figure 11. Pneumococcal Product Picture
    Figure 12. Global Human Vaccine Sales Market Share by Application in 2021 & 2027
    Figure 13. Adults Examples
    Figure 14. Children Examples
    Figure 15. Human Vaccine Report Years Considered
    Figure 16. Global Human Vaccine Market Size, (US$ Million), 2016 VS 2021 VS 2027
    Figure 17. Global Human Vaccine Market Size 2016-2027 (US$ Million)
    Figure 18. Global Human Vaccine Sales 2016-2027 (K Units)
    Figure 19. Global Human Vaccine Market Size Market Share by Region: 2021 Versus 2027
    Figure 20. Global Human Vaccine Sales Market Share Forecast by Region (2016-2027)
    Figure 21. Global Human Vaccine Revenue Market Share by Region (2016-2027)
    Figure 22. Global Human Vaccine Sales Share by Manufacturer in 2020
    Figure 23. Human Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
    Figure 24. Global Human Vaccine Sales Market Share Forecast by Type (2016-2027)
    Figure 25. Global Human Vaccine Revenue Market Share Forecast by Type (2016-2027)
    Figure 26. Human Vaccine Average Selling Price (ASP) by Type (2016-2021) & (USD/Unit)
    Figure 27. Global Human Vaccine Sales Market Share Forecast by Application (2016-2027)
    Figure 28. Global Human Vaccine Revenue Market Share Forecast by Application (2016-2027)
    Figure 29. Human Vaccine Average Selling Price (ASP) by Application (2016-2021) & (USD/Unit)
    Figure 30. North America Human Vaccine Revenue 2016-2027 (US$ Million)
    Figure 31. North America Human Vaccine Sales Market Share by Type (2016-2021)
    Figure 32. North America Human Vaccine Sales Market Share by Application (2016-2021)
    Figure 33. Asia-Pacific Human Vaccine Revenue 2016-2027 (US$ Million)
    Figure 34. Asia-Pacific Human Vaccine Sales Market Share by Region (2016-2027)
    Figure 35. Asia-Pacific Human Vaccine Revenue Market Share by Region (2016-2027)
    Figure 36. Asia-Pacific Human Vaccine Sales Market Share by Type (2016-2021)
    Figure 37. Asia-Pacific Human Vaccine Sales Market Share by Application (2016-2021)
    Figure 38. Europe Human Vaccine Revenue Growth Rate 2016-2027 (US$ Million)
    Figure 39. Europe Human Vaccine Sales Market Share by Country (2016-2027)
    Figure 40. Europe Human Vaccine Revenue Market Share by Country (2016-2027)
    Figure 41. Europe Human Vaccine Sales Market Share by Type (2016-2021)
    Figure 42. Europe Human Vaccine Sales Market Share by Application (2016-2021)
    Figure 43. Latin America Human Vaccine Revenue Growth Rate 2016-2027 (US$ Million)
    Figure 44. Latin America Human Vaccine Sales Market Share by Country (2016-2027)
    Figure 45. Latin America Human Vaccine Revenue Market Share by Country (2016-2021)
    Figure 46. Latin America Human Vaccine Sales Market Share by Type (2016-2021)
    Figure 47. Latin America Human Vaccine Sales Market Share by Application (2016-2021)
    Figure 48. Middle East and Africa Human Vaccine Revenue Growth Rate 2016-2027 (US$ Million)
    Figure 49. Middle East and Africa Human Vaccine Sales Market Share by Country (2016-2027)
    Figure 50. Middle East and Africa Human Vaccine Revenue Market Share by Country (2016-2027)
    Figure 51. Middle East and Africa Human Vaccine Sales Market Share by Type (2016-2021)
    Figure 52. Middle East and Africa Human Vaccine Sales Market Share by Application (2016-2021)
    Figure 53. Human Vaccine Supply Chain (Upstream and Downstream Market)
    Figure 54. Global Production Market Share of Human Vaccine Raw Materials by Region in 2020
    Figure 55. Human Vaccine Distribution Channels
    Figure 56. Global Human Vaccine Percentage 2016-2027: Indirect Sales VS Direct Sales
    Figure 57. Global Human Vaccine Percentage 2016-2027: Online Sales VS Offline Sales
    Figure 58. Porter's Five Forces Analysis
    Figure 59. Bottom-up and Top-down Approaches for This Report
    Figure 60. Data Triangulation
    Figure 61. Key Executives Interviewed
SELECT A FORMAT
Added to Cart

Electronic (PDF)
$5900
This license allows only one user(purchaser of the report) to access the PDF.

Electronic (PDF)
$8850
This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Electronic (PDF)
$11800
This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (10% Discount)
OUR CUSTOMER
Accenture

RELATED REPORTS

Global and China Mycobacterium Tuberculosis Antibodies Market Insights Forecast to 2027
Global and China Mycobacterium Tuberculosis Antibodies Market Insights, Forecast to 2027

120 Pages
Type: Report
Code: QYRE-Auto-15D7777
Wed Nov 24 00:00:00 UTC 2021

Add to Cart

Global and China Escherichia Coli Antibody Market Insights Forecast to 2027
Global and China Escherichia Coli Antibody Market Insights, Forecast to 2027

120 Pages
Type: Report
Code: QYRE-Auto-20G7629
Wed Nov 24 00:00:00 UTC 2021

Add to Cart

Global and United States Chlamydia Trachomatis Antibodies Market Insights Forecast to 2027
Global and United States Chlamydia Trachomatis Antibodies Market Insights, Forecast to 2027

120 Pages
Type: Report
Code: QYRE-Auto-21F7760
Wed Nov 24 00:00:00 UTC 2021

Add to Cart

Global and China Prophylactic HIV Drug Market Insights Forecast to 2027
Global and China Prophylactic HIV Drug Market Insights, Forecast to 2027

120 Pages
Type: Report
Code: QYRE-Auto-7T7637
Sun Nov 21 00:00:00 UTC 2021

Add to Cart